Universe Pharmaceuticals INC Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
Universe Pharmaceuticals INC (UPC) reported Increase (Decrease) in Other Accounts Payable and Accrued Liabilities of -$706.07 million for the 12-month period ending 2025-09-30, per its 20-F filed 2026-01-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities · last filed 2026-01-29
| Period end | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 12 month |
|---|---|
| 2025-09-30 | -$706.07M 20-F · filed 2026-01-29 |
| 2024-09-30 | -$1.14B 20-F · filed 2026-01-29 |
| 2023-09-30 | $73.97M 20-F · filed 2026-01-29 |